Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-07

Clinical Trial Update: Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing cotrimoxazole with amoxicillin for community-acquired pneumonia in children aged 2-59 months has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Cotrimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Makerere University | Conditions: Childhood Pneumonia | Phase 3 | Status: COMPLETED